EAF2, ELL associated factor 2, 55840

N. diseases: 35; N. variants: 0
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms
0.350 Biomarker group BEFREE ELL-associated factor 1 is a transcription elongation factor that shares significant homology and functional similarity to the androgen-responsive prostate tumor suppressor ELL-associated factor 2. 31229879 2019
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms
0.350 Biomarker group BEFREE Elongation factor, RNA polymerase II, 2 (ELL2) is an RNA Pol II elongation factor with functional properties similar to ELL that can interact with the prostate tumor suppressor EAF2. 28870994 2017
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms
0.350 PosttranslationalModification group BEFREE These findings suggest that EAF2 and p53 functionally interact in prostate tumor suppression and that simultaneous inactivation of EAF2 and p53 can drive prostate carcinogenesis. 29029019 2017
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms
0.350 Biomarker group BEFREE These results suggest that the EAF2 knockout mouse on the C57BL/6J and FVB/NJ genetic backgrounds provides a model of PIN lesions associated with an altered prostate microvasculature and reactive stromal compartment corresponding to that reported in human prostate tumors. 24260246 2013
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms
0.350 Biomarker group CTD_human Inhibition of 5alpha-reductase enhances testosterone-induced expression of U19/Eaf2 tumor suppressor during the regrowth of LNCaP xenograft tumor in nude mice. 20564326 2010
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms
0.350 AlteredExpression group LHGDN Suppression of prostate tumor growth by U19, a novel testosterone-regulated apoptosis inducer. 12907652 2003